Annual report for Thyrocare Technologies Ltd. for FY-2016
13-06-2016
Board recommends Final Dividend
Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 11, 2016, inter alia, have recommended a payment of final dividend of Rs. 2.50 (Rupees Two and Paise Fifty only) per equity share of the face value of Rs. 10 each for the financial year ended March 31, 2016. The Company has declared two interim dividends. These two interim dividends constitutes a total payout of Rs. 7.50 per equity share...11-06-2016
Standalone & Consolidated Financial Results, Auditors Report for March 31, 2016
Thyrocare Technologies Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 20164. Consolidated Auditors Report for the period ended March 31, 201611-06-2016
Board to consider Final Dividend
Thyrocare Technologies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 11, 2016, inter alia, to consider the following subjects :1. Audited Stand-alone financial results of the Company for the quarter and financial year ended March 31, 2016 and Audited, consolidated financial results of the Company and its subsidiary for the quarter and financial year ended March 31, 2016....04-06-2016
A Velumani: Life, loss and white lies
Thyrocare founder Arokiaswamy Velumani shares his rags to riches story with author as he remembers the one person who stood by him through it all03-06-2016
Intimation of Conference on June 03, 2016
Thyrocare Technologies Ltd has informed BSE that the Chairman & Managing Director, Dr. A Velumani , has been invited to participate at a conference organized by M/s. Batlivala & Karani Securities India P. Ltd., at Hotel Trident, BKC, on June 03, 2016, where the fund managers will have a meeting with the Chairman & Managing Director01-06-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Thyrocare Technologies Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".23-05-2016
Updates on Intimation of Schedule of Analyst / Institutional Investor Meetings
With reference to earlier letter dated May 17, 2016 regarding Plant Visit, Thyrocare Technologies Ltd has now informed BSE about details of meeting by Analyst / Institutional investors on May 25, 2016.18-05-2016
Updates - Intimation of Schedule of Analyst / Institutional Investor Meetings
Thyrocare Technologies Ltd has submitted to BSE a copy of a Letter of Disclosure of plant visit by Analyst / Institutional Investor followed by one-to-one meeting, on May 26, 2016.18-05-2016
Shareholding for the Period Ended May 05, 2016
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended May 05, 2016. For more details, kindly Click here17-05-2016